Biotech News
Centessa Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares
investors.centessa.com2026-05-06 14:59 EST
BOSTON and LONDON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that it has commenced an underwritten public offering of American Depositary Shares (“ADSs”), each representing one ordinary share.